{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:50:37Z","timestamp":1791417037730,"version":"4.3.3"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD021644-011A1"],"award-info":[{"award-number":["1S10OD021644-011A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jvs.2026.02.032","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:17:09Z","timestamp":1772583429000},"page":"178-188.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness and safety of rivaroxaban following peripheral arterial endovascular revascularization in real-world practice"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9976-928X","authenticated-orcid":false,"given":"Alexander M.","family":"Schurman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Horns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Libby","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan M.","family":"Droz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4361-9255","authenticated-orcid":false,"given":"Mark R.","family":"Sarfati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cali E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4183-8825","authenticated-orcid":false,"given":"Chris O.","family":"Audu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaohinani J.","family":"Longwolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-651X","authenticated-orcid":false,"given":"Muyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Brooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2026.02.032_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0031-1278244","article-title":"Peripheral arterial disease: epidemiology, natural history, diagnosis and treatment","volume":"16","author":"Dhaliwal","year":"2007","journal-title":"Int J Angiol"},{"key":"10.1016\/j.jvs.2026.02.032_bib2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jvs.2022.09.007","article-title":"High-intensity statin therapy reduces risk of amputation and reintervention among patients undergoing lower extremity bypass for chronic limb-threatening ischemia","volume":"77","author":"He","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.02.032_bib3","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2026.02.032_bib4","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jvs.2026.02.032_bib6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","article-title":"STROBE reporting guidelines for observational studies","volume":"156","author":"Ghaferi","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jvs.2026.02.032_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/ajhp\/zxab392","article-title":"Proportion of days covered as a measure of medication adherence","volume":"79","author":"Loucks","year":"2022","journal-title":"Am J Health Syst Pharm"},{"issue":"8 Suppl 3","key":"10.1016\/j.jvs.2026.02.032_bib8","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","article-title":"Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases","volume":"51","author":"Raebel","year":"2013","journal-title":"Med Care"},{"key":"10.1016\/j.jvs.2026.02.032_bib9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","article-title":"Reducing bias in observational studies using subclassification on the propensity score","volume":"79","author":"Rosenbaum","year":"1984","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jvs.2026.02.032_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brat.2017.01.005","article-title":"A practical guide to propensity score analysis for applied clinical research","volume":"98","author":"Lee","year":"2017","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.jvs.2026.02.032_bib11","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jvs.2007.07.046","article-title":"The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure","volume":"46","author":"Brumberg","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.02.032_bib12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0741-5214(98)70130-2","article-title":"Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure","volume":"28","author":"Sarac","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.02.032_bib13","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.jacc.2018.03.483","article-title":"Antithrombotic therapy for peripheral artery disease: recent advances","volume":"71","author":"Hussain","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2026.02.032_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehn534","article-title":"Patients with peripheral arterial disease in the CHARISMA trial","volume":"30","author":"Cacoub","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2026.02.032_bib15","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"Gent","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2026.02.032_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa065959","article-title":"Oral anticoagulant and antiplatelet therapy and peripheral arterial disease","volume":"357","author":"Anand","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jvs.2026.02.032_bib17","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jamasurg.2016.0415","article-title":"Efficacy of a guideline-recommended risk-reduction program to improve cardiovascular and limb outcomes in patients with peripheral arterial disease","volume":"151","author":"Hussain","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jvs.2026.02.032_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jvs.2026.02.032_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jvs.2025.04.041","article-title":"Society for Vascular Surgery Clinical Practice Guideline on the management of intermittent claudication: focused update","volume":"82","author":"Conte","year":"2025","journal-title":"J Vasc Surg"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521426001606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521426001606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:11:37Z","timestamp":1791414697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521426001606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0741521426001606"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2026.02.032","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of rivaroxaban following peripheral arterial endovascular revascularization in real-world practice","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2026.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society for Vascular Surgery. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}